药物对比
Canagliflozin vs Dulaglutide
比较Canagliflozin与Dulaglutide治疗2型糖尿病。Invokana（SGLT2抑制剂）与Trulicity（GLP-1）：作用方式、获益、风险，以及哪种更适合您。
此页面暂无可用的对比维度。
临床背景
This comparison is triggered when selecting between an oral SGLT2 inhibitor and an injectable GLP-1 agonist for type 2 diabetes, particularly with heart failure, CKD, or obesity considerations.
结论
The preferred option between Canagliflozin and Dulaglutide varies by patient factors like pill versus injection preference, specific organ protection needs, and individual risk profiles rather than one being universally superior.
全部药物对比